Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Alendronate versus alfacalcidol (1-alpha OH vitamin D)[3] Alendronic acid,
Alfacalcidol,
Vitamin D		[2] D01518 (Name: Alfacalcidol),
D07119 		[2] FDPS,
VDR 💬		[9] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis 💬[3] 41, 46, 50
2Alfacalcidol[1] Alfacalcidol[1] D01518 (Name: Alfacalcidol)[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[8] 41, 46, 49, 50, 96, 107, 235, 238
3Alfacalcidol 2 micrograms/ml[1] Alfacalcidol[1] D01518 (Name: Alfacalcidol)[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[2] 50, 107
4Ibandronate+alfacalcidol+calcium[3] Alfacalcidol,
Calcium,
Ibandronate		[1] D01518 (Name: Alfacalcidol)[1] VDR 💬[5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 49